Filing Details
- Accession Number:
- 0000899243-19-010836
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2019-04-17 20:25:00
- Reporting Period:
- 2018-01-02
- Accepted Time:
- 2019-04-17 20:25:00
- Original Submission Date:
- 2018-01-03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1552451 | Myokardia Inc | MYOK | Pharmaceutical Preparations (2834) | 455500552 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1654909 | Jake Bauer | C/O Myokardia, Inc. 333 Allerton Avenue South San Francisco CA 94080 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-01-02 | 5,000 | $12.25 | 71,777 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-01-02 | 3,900 | $42.76 | 67,877 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-01-02 | 1,100 | $43.38 | 66,777 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-01-02 | 5,000 | $0.00 | 5,000 | $12.25 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 54,850 | 2027-01-17 | No | 4 | M | Direct |
Footnotes
- This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- These shares were omitted from the Reporting Person's original Form 4, and also were omitted from the subsequent Form 4s filed by the Reporting Person through the date of this amendment
- Represents the weighted average sale price of the shares sold ranging from $42.20 to $43.15 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average sale price of the shares sold ranging from $43.20 to $43.60 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- The shares underlying the option vest in 48 equal monthly installments from January 1, 2017, so long as the Reporting Person continues to be an employee of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.
Billionaire Hedge Funds
